Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.42% | -13.46% | -169.44% | -174.85% | -2.51% |
| Total Depreciation and Amortization | 15.67% | 6.34% | -13.57% | -11.81% | -24.97% |
| Total Amortization of Deferred Charges | -- | -- | -83.11% | -82.78% | -- |
| Total Other Non-Cash Items | 966.84% | 881.39% | 80.72% | 80.33% | -86.13% |
| Change in Net Operating Assets | 47.30% | 51.55% | 547.07% | 556.08% | 30.03% |
| Cash from Operations | -2.10% | 6.14% | 70.81% | 70.23% | -3.77% |
| Capital Expenditure | 85.32% | 86.50% | 16.87% | 15.19% | -41.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -159.34% | -154.54% | -103.85% | -103.93% | -97.14% |
| Cash from Investing | 56.76% | 60.25% | -110.45% | -110.66% | -107.99% |
| Total Debt Issued | 1.50% | 1.50% | -- | -- | -- |
| Total Debt Repaid | 98.54% | 98.54% | 87.46% | 87.46% | -91.31% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -159.60% | -159.60% | 116.07% | 116.07% | 231.91% |
| Cash from Financing | 9.88% | 1.02% | -37.73% | -36.48% | 2,181.04% |
| Foreign Exchange rate Adjustments | -469.53% | -439.80% | -- | -- | 5,765.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.10% | 128.59% | -88.81% | -88.59% | 49.91% |